January 2012 Volume 8, Issue 1
Volume 8, Issue 1 | January 2012
January 2012
In this Issue
Research & Development
Curing from hand to mouth
Gilead Sciences acquires Pharmasset for $11 billion in hopes of more quickly advancing oral, non-interferon treatments for HCVA positive outcome for breast cancer patients
Galena Biopharma collaborates with Genentech/Roche, HJF in clinical trials of NeuVax for prevention of breast cancer recurrencesHands across Kendall Square
MIT and Pfizer begin work on new partnership spaceThe power of three
Roche, PTC Therapeutics and the SMA Foundation go after potential treatment for Spinal Muscular AtrophyWaste not, want not
New UCSF, GE Healthcare to collaborate on umbilical cord blood projectDiagnostics
Growing steadily downstream
Affymetrix to acquire eBioscience for $330 million in plan to expand beyond discovery-based effortsRoadmap to theranostics
Researchers awarded $3.2 million from NIH Roadmap to pioneer advanced biomolecule discovery technologyDeal aggressively targets oncology Dx
GSK and Abbott expand collaboration to develop additional companion diagnostic test for several types of cancerMDxHealth, Celldex ink deal for brain cancer test
Companies begin Phase III study for glioblastoma multiforme testTrauma on their minds, treatment in their thoughts
Amarantus Biosciences and Banyan Biomarkers announce traumatic brain injury research collaborationGlobal News
‘The next big thing is already here’
Samsung furthers entrée into growing biosimilars market in $300 million joint venture with Biogen IdecGood cop, bad cop, market share
Valeant shows both its amiable and hostile sides with an agreement to acquire Australia’s iNova and a hostile bid to take over U.S. company ISTA PharmaceuticalsA ‘win, win, win’ for public-private partners
AstraZeneca launches innovative partnership with U.K.’s Medical Research Council for discontinued drug compoundsThe appeal of zeal
Elan to join Cambridge in new research center aimed at neurodegenerative diseasesThe eyes have it
Proximagen, Altacor to collaborate on glaucoma treatmentOmics & Systems Biology
Genes that fit everyone
NIH division paves path toward genomic medicineChanging the channel
UCB acquires ion channel-targeting programs from Lectus TherapeuticsAn alternative to whole-genome sequencing
Roche NimbleGen, BGI unveil MHC region capture technology for human disease and biomedical researchGoing commercial
Compugen, DiscoveRx form collaboration to commercialize novel peptide ligands for GPCR drug targetsBruker goes to Korea
Company will collaborate with Chungnam National University in Korea to develop reference site on glycomics methods for biopharmaceuticals and biosimilarsCommentary
Examining recent approaches to treating solid tumors
According to the Centers for Disease Control and Prevention, the top 10 cancer types are in the solid tumor category; today, the priority is likely even higher. Thus, there are clear unmet medical needs, and the development of new, cost-efficient and patient-friendly treatments remain a high priority for both the healthcare community and patients.Out of Order: Gift horses
A quick Google search for the phrase “outcomes-based medicine” yields results in the tens of thousands. When you look at a lot of these results, however, the focus is on scientific method and not, ironically, on outcomes—which is the point of medicine, isn’t it?Editor's Focus
Keeping our resolution to report the news
From publishing our single newspaper in January 2005 to celebrating our eighth year in 2012, ddn continues to produce many vehicles that disseminate the news.Government Watch
Meeting the need for speed
Draft federal legislation addresses FDA issues, including faster drug approvalsA high-stakes dispute
U.S. Supreme Court hears oral arguments from Prometheus and Mayo over validity of challenged patentGenetic testing garners lawmaker’s attention
Texas Congressman hopes to block FDA from increased regulation of laboratory-developed genetic testsFeature
Rebooted and upgraded - SLAS2012 Show Preview
The merged ALA and SBS groups, now known as SLAS, launch first-ever joint annual meetingThe social side of SLAS2012
Events at the show and attractions in San DiegoTools & Technology
Growth in India
AB SCIEX acquires Labindia’s mass spectrometry division to broaden presence in IndiaCorning Life Sciences acquires Mediatech
Corning to offer customers a more complete solution to their cell culture and bioprocess needsShopping for companies during the holidays
Agilent Technologies grows life- science business with strategic acquisitions in next-generation sequencing and automated analytical solutions for pharmaAn unfolding development
Expedeon and Protein Discovery join forces to provide advanced products for protein research
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
